Anti-Aminopeptidase N [mami1 - 2E710.1]
Invented by Prof Dallas Swallow from GEE UCL
Invented at University College London
- Datasheet
- References (1)
- Inventor Info
Info
| Catalogue Number | 151694 |
| Applications | IHC IP |
| Antigen/Gene or Protein Targets | Human small intestinal aminopeptidase; aminipeptidase N; Alanyl aminopeptidase |
| Synonyms | AMPN_HUMAN, APN, CD13, PEPN |
| Reactivity | Human |
| Relevance |
The mami1 antibody is directed to aminopeptidase N and has been (successfully) used for immunoprecipitation of aminopeptidase N from the small intestine. APN is a receptor for the coronavirus 229E/HCoV-229E spike protein. |
| Host | Mouse |
| Immunogen | Normal jejunal epithelial brush border-enriched membranes from a non-secretor, blood group O |
| Immunogen UniProt ID | P15144 (AMPN_HUMAN) |
| Subclass | Not Known |
| Myeloma Used | P3/NS1/1-Ag4.1 |
| Recommended Growing Conditions | RPMI 1640 + 20% FCS containing 10-6 M thymidine, 1.6x10-7 M hypoxanthine and 10-5 M methotrexate. |
| Strain | Balb/c |
| Notes | Other Applications: EIA |
| Research Area | Cell Structure and Motility |
